Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 3.51%, near the low end of its 5-year range (0.00%–12.12%).
As of the fiscal period ended Sunday, May 31, 2026. 100.00% below its 12-month average of 3.20%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2026 (2026-05-31): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
3.20%
DEBT TO ASSETS RATIO AVG 3Y
2.13%
DEBT TO ASSETS RATIO AVG 5Y
3.51%
DEBT TO ASSETS RATIO AVG 10Y
7.91%
DEBT TO ASSETS RATIO AVG 15Y
10.51%
DEBT TO ASSETS RATIO AVG 20Y
8.54%
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 669 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
AngioDynamics, Inc.
Market Cap
$611.93M
Debt to Assets Ratio
0.00%
TTM Avg
3.20%
3Y Avg
2.13%
5Y Avg
3.51%
Market Cap
$615.25M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$600.84M
Debt to Assets Ratio
1.39%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$594.43M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$584.33M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$643.89M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$572.98M
Debt to Assets Ratio
0.45%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$569.29M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $611.93M | 0.00% | 3.20% | 2.13% | 3.51% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $615.25M | 0.00% | N/A | N/A | N/A |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 1.39% | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $594.43M | 0.01% | N/A | N/A | N/A |
| Climb Bio, Inc. (CLYM)vs › | $637.92M | 0.01% | N/A | N/A | N/A |
| OrthoPediatrics Corp. (KIDS)vs › | $584.33M | 0.18% | N/A | N/A | N/A |
| Aura Biosciences, Inc. (AURA)vs › | $643.89M | 0.05% | N/A | N/A | N/A |
| Aquestive Therapeutics, Inc. (AQST)vs › | $572.98M | 0.45% | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $569.29M | 0.01% | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $563.68M | 0.16% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
2.19
Interest Coverage
-133.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-05-31 | 0.00% |
| 2026-02-28 | 4.37% |
| 2025-11-30 | 4.37% |
| 2025-08-31 | 3.61% |
| 2025-05-31 | 3.62% |
| 2025-02-28 | 1.75% |
| 2024-11-30 | 1.70% |
| 2024-08-31 | 1.64% |
| 2024-05-31 | 1.49% |
| 2024-02-29 | 1.22% |
| 2023-11-30 | 0.84% |
| 2023-08-31 | 0.96% |
| 2023-05-31 | 12.12% |
| 2023-02-28 | 10.99% |
| 2022-11-30 | 8.92% |
| 2022-08-31 | 8.93% |
| 2022-05-31 | 6.11% |
| 2022-02-28 | 4.60% |
| 2021-11-30 | 4.51% |
| 2021-08-31 | 4.50% |
| 2021-05-31 | 3.56% |
| 2021-02-28 | 5.15% |
| 2020-11-30 | 6.80% |
| 2020-08-31 | 6.85% |
| 2020-05-31 | 6.86% |
| 2020-02-29 | 2.08% |
| 2019-11-30 | 0.12% |
| 2019-08-31 | 0.13% |
| 2019-05-31 | 16.32% |
| 2019-02-28 | 17.97% |
| 2018-11-30 | 18.91% |
| 2018-08-31 | 13.61% |
| 2018-05-31 | 13.28% |
| 2018-02-28 | 13.58% |
| 2017-11-30 | 13.76% |
| 2017-08-31 | 14.96% |
| 2017-05-31 | 14.96% |
| 2017-02-28 | 15.20% |
| 2016-11-30 | 17.50% |
| 2016-08-31 | 18.05% |
| 2016-05-31 | 18.33% |
| 2016-02-29 | 18.46% |
| 2015-11-30 | 18.90% |
| 2015-08-31 | 18.97% |
| 2015-05-31 | 19.08% |
| 2015-02-28 | 20.27% |
| 2014-11-30 | 20.64% |
| 2014-08-31 | 19.10% |
| 2014-05-31 | 19.19% |
| 2014-02-28 | 19.07% |
| 2013-11-30 | 19.16% |
| 2013-08-31 | 19.37% |
| 2013-05-31 | 19.16% |
| 2013-02-28 | 19.27% |
| 2012-11-30 | 18.78% |
| 2012-08-31 | 20.63% |
| 2012-05-31 | 20.69% |
| 2012-02-29 | 1.42% |
| 2011-11-30 | 1.45% |
| 2011-08-31 | 1.48% |
| 2011-05-31 | 1.50% |
| 2011-02-28 | 1.53% |
| 2010-11-30 | 1.57% |
| 2010-08-31 | 1.60% |
| 2010-05-31 | 1.61% |
| 2010-02-28 | 1.67% |
| 2009-11-30 | 1.70% |
| 2009-08-31 | 1.71% |
| 2009-05-31 | 1.73% |
| 2009-02-28 | 1.79% |
| 2008-11-30 | 1.84% |
| 2008-08-31 | 1.85% |
| 2008-05-31 | 4.19% |
| 2008-02-29 | 4.33% |
| 2007-11-30 | 4.40% |
| 2007-08-31 | 4.51% |
| 2007-05-31 | 4.55% |
| 2007-03-03 | 4.64% |
| 2006-12-02 | 1.91% |
| 2006-09-02 | 2.04% |
| 2006-06-03 | 2.14% |
| 2006-02-25 | 4.24% |
| 2005-11-26 | 4.70% |
| 2005-08-27 | 5.00% |
| 2005-05-28 | 5.20% |
| 2005-02-26 | 5.83% |
| 2004-11-27 | 6.31% |
| 2004-08-28 | 6.62% |
| 2004-05-29 | 12.58% |
| 2004-02-29 | 66.86% |
| 2003-05-31 | 72.23% |
